The evolving landscape of malaria necessitates a dynamic approach to management standards. Current recommendations, often guided by the World Health Organization Global Body, prioritize the use of artemisinin-based combination treatments (ACTs) as first-line therapy in most endemic regions. However, the rise of artemisinin immunity demands careful

A new drug is generating hope in the medical community, as it shows encouraging results for both weight loss and diabetes management. In ongoing clinical trials, individuals taking the medication experienced noticeable reductions in BMI. Moreover, the drug also demonstrated measurable benefits in blood sugar control for patients with type 2 diabete